Advertisement

Topics

New Alzheimer's drug shows promise in early-stage human trials

05:47 EDT 17 May 2019 | SmartBrief

German researchers found that the new Alzheimer's disease drug PRI-002, which removes toxic beta-amyloid oligomers, was safe  -More

Original Article: New Alzheimer's drug shows promise in early-stage human trials

NEXT ARTICLE

More From BioPortfolio on "New Alzheimer's drug shows promise in early-stage human trials"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...